We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.07%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$7.57B
AUM Growth
+$643M
(+9.3%)
Cap. Flow
+$235M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
16.13%
Holding
1,154
New
305
Increased
228
Reduced
235
Closed
370
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$71M |
| 2 |
Baxter International
BAX
|
+$60.7M |
| 3 |
T-Mobile US
TMUS
|
+$60.1M |
| 4 |
Perrigo
PRGO
|
+$53.7M |
| 5 |
NRG Energy
NRG
|
+$50.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$68.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$53.3M |
| 3 |
Avient
AVNT
|
+$45.7M |
| 4 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$45.6M |
| 5 |
BHI
Baker Hughes
BHI
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.11% |
| 2 | Industrials | 11.84% |
| 3 | Consumer Discretionary | 11.65% |
| 4 | Technology | 10.61% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
OGE Energy
OGE
$9.71B
| $2.44M | 0.03% |
68,757
+14,218
| +26% | +$513K |
|
|
AXLL
427
DELISTED
AXIALL CORP COM STK (DE)
AXLL
| $2.43M | 0.03% |
57,300
-2,247
| -4% | -$91.5K |
|
428
Edgewell Personal Care
EPC
$1.35B
| $2.43M | 0.03% |
25,461
+21,236
| +503% | +$1.95M |
|
429
Darling Ingredients
DAR
$9.19B
| $2.4M | 0.03% |
+132,100
| New | +$2.39M |
|
430
Allegiant Air
ALGT
$2.79B
| $2.36M | 0.03% |
+15,695
| New | +$2.06M |
|
431
Asbury Automotive
ABG
$3.94B
| $2.36M | 0.03% |
+31,030
| New | +$2.23M |
|
432
PVH
PVH
$4.01B
| $2.34M | 0.03% |
18,231
-174,795
| -91% | -$21M |
|
433
NextEra Energy
NEE
$179B
| $2.31M | 0.03% |
+87,028
| New | +$2.2M |
|
|
GST
434
DELISTED
Gastar Exploration Inc.
GST
| $2.29M | 0.03% |
950,523
-186,604
| -16% | -$680K |
|
|
MASI
435
DELISTED
Masimo
MASI
| $2.27M | 0.03% |
86,337
-106,773
| -55% | -$2.64M |
|
|
HZNP
436
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $2.27M | 0.03% |
176,311
-28,037
| -14% | -$351K |
|
|
SLH
437
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $2.24M | 0.03% |
43,748
-271,059
| -86% | -$14.2M |
|
438
Universal Corp
UVV
$1.3B
| $2.24M | 0.03% |
+50,880
| New | +$2.14M |
|
|
CAVM
439
DELISTED
Cavium, Inc.
CAVM
| $2.23M | 0.03% |
+35,986
| New | +$1.9M |
|
|
IPG
440
DELISTED
Interpublic Group of Companies
IPG
| $2.2M | 0.03% |
105,939
-38,523
| -27% | -$741K |
|
441
Constellation Brands
STZ
$22.3B
| $2.2M | 0.03% |
22,405
-59,016
| -72% | -$5.4M |
|
|
PL
442
DELISTED
PROTECTIVE LIFE CORP
PL
| $2.19M | 0.03% |
31,455
-6,212
| -16% | -$432K |
|
443
Methanex
MEOH
$4.02B
| $2.17M | 0.03% |
47,461
+11,694
| +33% | +$638K |
|
444
Constellium
CSTM
$4.02B
| $2.17M | 0.03% |
131,883
-565,424
| -81% | -$10.5M |
|
|
IPCM
445
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $2.13M | 0.03% |
46,529
+7,521
| +19% | +$327K |
|
446
Jazz Pharmaceuticals
JAZZ
$17B
| $2.13M | 0.03% |
13,032
+11,595
| +807% | +$1.92M |
|
447
Hilton Worldwide
HLT
$73B
| $2.12M | 0.03% |
27,118
+23,435
| +636% | +$1.76M |
|
448
Visa
V
$688B
| $2.12M | 0.03% |
32,368
-379,120
| -92% | -$22.8M |
|
|
AMWD
449
DELISTED
American Woodmark
AMWD
| $2.11M | 0.03% |
+52,137
| New | +$2.05M |
|
|
DRYS
450
DELISTED
DryShips Inc. Common Stock
DRYS
| – | – |
0
| – | – |
|
Similar funds
Marshall Wace's Q4 2014 Portfolio in Review
As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $235M of net new capital in Q4 2014, opening 305 new positions and adding to 228 existing holdings. Its largest new stake was Baxter International: 1,557,838 shares worth $62M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.
- Marshall Wace's largest Q4 2014 buy was Baxter International: 1,557,838 shares worth $62M.
- Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
- Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
- Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
- Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
- Marshall Wace opened 305 new positions and closed 370 in Q4 2014.
- Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.
Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.